• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, September 11, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

UNIST startup receives KRW 1 billion investment from KIBO

Bioengineer.org by Bioengineer.org
January 30, 2018
in Headlines, Health, Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: AZA Studio SeoYeon Lee

p>RecensMedical Inc., a UNIST-based startup company, has been selected as the first investment enterprise of U-TECH Valley by the Korea Technology Finance Corporation (KIBO).

Launched in January of this year by KIBO, the U-TECH Valley is a platform that supports rapid commercialization of cutting-edge technologies developed at universities and research institutes in South Korea. For the U-TECH Valley platform, KIBO has made agreements with 56 universities and 15 research institutes nationwide. Aside from commercializing excellent research outcomes, the platform aims to financially support researchers and startups without financial burden of failure.

The companies, supported by the U-TECH Valley platform will receive both financial guarantees and investments from KIBO, which amounts up to 3 billion KRW. With the help of KIBO's full financial support, along with their promising technologies, the selected companies have a unique opportunity to achieve rapid succeed.

"Under this agreement, researchers at universities can move their technologies forward with sufficient funding without having to worry about joint guarantees," says KIBO Chairman and President Kyu-ok Kim. "We will take the lead in helping universities contribute to the growth of the national economy in the era of the Fourth Industrial Revolution."

Founded in 2016 by Professor Gun-Ho Kim (School of Mechanical, Aerospace and Nuclear Engineering) at UNIST, RecensMedical Inc. has been selected as the first U-TECH Valley company and received 1 billion KRW investment and 2 billion KRW financial guarantees from KIBO. The funding will help accelerate the commercialization of its rapid cooling anesthesia for not only the painless intravitreal injection therapy and the standard care for rapidly growing retinal diseases, but also painless laser therapies and needle injections in dermatology.

Meanwhile, RecensMedical Inc. is the first venture company in Ulsan, supported by TIPS (Accelerator Investment-Driven Tech Incubator Program for Startups) of the Ministry of SMEs and Startups (MSS). In less than 6 months, it has once again been selected as the first U-TECH Valley company, making a new history of venture startups in Ulsan.

###

Media Contact

JooHyeon Heo
[email protected]
82-522-171-223

home

Original Source

UNIST Startup Receives KRW 1 Billion Investment from KIBO

Share12Tweet8Share2ShareShareShare2

Related Posts

Discovering a Female-Specific Mechanism Regulating Energy Expenditure in Brown Fat

September 11, 2025
Dr. Michael Welsh Honored with Lasker Award for Groundbreaking Cystic Fibrosis Research

Dr. Michael Welsh Honored with Lasker Award for Groundbreaking Cystic Fibrosis Research

September 11, 2025

Mass General Brigham’s Kraft Center Reveals Winner and Finalists for 2025 Kraft Prize in Community Health Innovation

September 11, 2025

Exploring Ginseng’s Diverse Benefits: A Summary of Its Immunomodulatory Effects, Quality of Life Enhancements, and Antitumor Properties

September 11, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    152 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    63 shares
    Share 25 Tweet 16
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Discovering a Female-Specific Mechanism Regulating Energy Expenditure in Brown Fat

Dr. Michael Welsh Honored with Lasker Award for Groundbreaking Cystic Fibrosis Research

Mass General Brigham’s Kraft Center Reveals Winner and Finalists for 2025 Kraft Prize in Community Health Innovation

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.